Refractory Or Relapsed Multiple Myeloma clinical trials

Explore recruiting refractory or relapsed multiple myeloma clinical trials.

Recruiting refractory or relapsed multiple myeloma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Or Relapsed Multiple Myeloma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-Blind, Randomized, Active Controlled, Parallel-group, Phase 1/3 Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination with Lenalidomide and Dexamethasone in Patients with Refractory or Relapsed Multiple Myeloma

Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Refractory Or Relapsed Multiple Myeloma trials by city

Refractory Or Relapsed Multiple Myeloma in Toronto Refractory Or Relapsed Multiple Myeloma in Vancouver Refractory Or Relapsed Multiple Myeloma in Montreal Refractory Or Relapsed Multiple Myeloma in Calgary Refractory Or Relapsed Multiple Myeloma in Edmonton Refractory Or Relapsed Multiple Myeloma in Ottawa Refractory Or Relapsed Multiple Myeloma in Winnipeg Refractory Or Relapsed Multiple Myeloma in Quebec City Refractory Or Relapsed Multiple Myeloma in Hamilton Refractory Or Relapsed Multiple Myeloma in Kitchener Refractory Or Relapsed Multiple Myeloma in London Refractory Or Relapsed Multiple Myeloma in Halifax Refractory Or Relapsed Multiple Myeloma in New York Refractory Or Relapsed Multiple Myeloma in Los Angeles Refractory Or Relapsed Multiple Myeloma in Chicago Refractory Or Relapsed Multiple Myeloma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease